Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our Level2View

SLN
Silence Therapeutics Plc
stock NASDAQ ADR

At Close
Aug 11, 2026 3:25:52 PM EDT
14.84USD-3.824%(-0.59)3,276,539
0.00Bid   0.00Ask   0.00Spread
Pre-market
Aug 11, 2026 9:27:30 AM EDT
16.02USD+3.824%(+0.59)9,280
After-hours
Aug 11, 2026 4:59:30 PM EDT
14.80USD-0.270%(-0.04)5,399
OverviewOption ChainMax PainOptionsHistoricalExchange VolumeDark Pool LevelsDark Pool PrintsExchangesShort VolumeShort Interest - DailyShort InterestBorrow Fee (CTB)Failure to Deliver (FTD)ShortsTrendsNewsNews
Jan 5, 2022
07:00AM EST  Silence Therapeutics to Participate in Fireside Chat at H.C. Wainwright BioConnect Virtual Conference   GlobeNewswire Inc
Dec 12, 2021
09:01AM EST  New Data from SLN124 Healthy Volunteer Study Reinforce Broad Therapeutic Potential in Hematological Diseases   GlobeNewswire Inc
Dec 1, 2021
07:00AM EST  Silence Therapeutics Welcomes Deep Track Capital as New Shareholder   GlobeNewswire Inc
Nov 30, 2021
07:00AM EST  Silence Therapeutics Begins Exclusive Nasdaq Trading   GlobeNewswire Inc
Nov 11, 2021
07:00AM EST  Silence Therapeutics to Present at Jefferies London Healthcare Conference   GlobeNewswire Inc
Nov 5, 2021
07:00AM EDT  Silence Therapeutics Welcomes Frazier Life Sciences as New Key Shareholder   GlobeNewswire Inc
Oct 21, 2021
08:30AM EDT  Silence Therapeutics Provides mRNAi GOLD Platform and Pipeline Updates at 2021 R&D Day   GlobeNewswire Inc
Oct 15, 2021
07:44AM EDT  The Daily Biotech Pulse: Moderna's Booster Shot Gets FDA Panel Backing, Decision Day For Avadel, Silence Therapeutics Strikes Licensing Deal, MiNK IPO   Benzinga
07:05AM EDT  Silence Announces Proposed Cancellation of Admission of its Ordinary Shares to Trading on AIM and Transition of its Primary Trading Venue to the Nasdaq Global Market   GlobeNewswire Inc
07:00AM EDT  Silence Therapeutics and Hansoh Pharma Announce Collaboration to Develop Therapeutics Leveraging Silences mRNAi GOLD Platform   GlobeNewswire Inc
Oct 7, 2021
07:00AM EDT  Silence Therapeutics to Host R&D Day on October 21, 2021   GlobeNewswire Inc
Sep 28, 2021
07:00AM EDT  Silence Therapeutics to Participate in Fireside Chat at the Chardan Virtual Genetic Medicines Conference   GlobeNewswire Inc
Sep 1, 2021
07:00AM EDT  Silence Therapeutics Appoints Dr. John Strafford as Senior Vice President, Business Development, Alliance Management and New Product Development   GlobeNewswire Inc
Aug 25, 2021
07:00AM EDT  Silence Therapeutics to Participate in September Investor Conferences   GlobeNewswire Inc
Aug 12, 2021
07:00AM EDT  Silence Therapeutics Reports Half-Year 2021 Results   GlobeNewswire Inc
Jul 15, 2021
07:00AM EDT  Silence Therapeutics Notice of Half Year Results   GlobeNewswire Inc
May 25, 2021
07:00AM EDT  Silence Therapeutics Receives Remaining $40 Million from AstraZeneca as Part of Upfront Investment for Ongoing siRNA Collaboration   GlobeNewswire Inc
May 19, 2021
09:19AM EDT  Silence Therapeutics' siRNA Candidate Reduces Plasma Iron Levels, Early-Stage Study Shows   Benzinga
07:30AM EDT  The Daily Biotech Pulse: Iovance To Delay Regulatory Filing For Cancer Therapy, Departures At Passage Bio, Positive Readout For Silence Therapeutics   Benzinga
07:00AM EDT  Silence Therapeutics Announces Positive Data from GEMINI Phase 1 Study of SLN124 in Healthy Volunteers   GlobeNewswire Inc
May 12, 2021
07:00AM EDT  Silence Therapeutics to Participate in Fireside Chat at the RBC Capital Markets Global Healthcare Conference   GlobeNewswire Inc
May 4, 2021
07:00AM EDT  Silence Therapeutics Launches New Video Game to Support International Thalassemia Day and Raise Disease Awareness   GlobeNewswire Inc
Apr 28, 2021
07:00AM EDT  Silence Therapeutics Achieves Another Research Milestone Payment from Mallinckrodt Collaboration for Complement-Mediated Diseases   GlobeNewswire Inc
Apr 15, 2021
07:00AM EDT  Silence Therapeutics Announces Publication in Cardiovascular Research Highlighting the Emerging Potential of RNA Therapeutics in Preventing Lipoprotein(a)-Mediated Cardiovascular Disease   GlobeNewswire Inc
Apr 7, 2021
07:00AM EDT  Silence Therapeutics to Present at the 20th Annual Needham Virtual Healthcare Conference   GlobeNewswire Inc
Mar 30, 2021
07:00AM EDT  Silence Therapeutics Reports Full-year 2020 ResultsAdvancing clinical programmes; On-track for three phase 1 data readouts in 2021   GlobeNewswire Inc
Mar 4, 2021
07:00AM EST  Silence Therapeutics to Present at the Barclays Global Healthcare Conference   GlobeNewswire Inc
Feb 26, 2021
08:17AM EST  The Daily Biotech Pulse: Adcom Test Awaits J&J's COVID-19 Vaccine, Lilly To Supply Additional Antibody Therapy Doses To US, Regulatory Setback For Tricida   Benzinga
07:00AM EST  Silence Therapeutics and Mallinckrodt Initiate Work on Third Target as Part of Ongoing RNAi Research Collaboration for Complement-Mediated Diseases   GlobeNewswire Inc
Feb 23, 2021
07:25AM EST  The Daily Biotech Pulse: Aridis To Study Antibody Cocktail For Coronavirus Variants, Revance & Protalix Data Readouts   Benzinga
Feb 22, 2021
07:00AM EST  Silence Therapeutics to Participate in March Investor Conferences   GlobeNewswire Inc
Feb 19, 2021
07:25AM EST  The Daily Biotech Pulse: Novavax Vaccine Supply Deal, Orphan Drug Designation For Travere, COVID-19 Boost For Quidel, Opko   Benzinga
Feb 18, 2021
08:14AM EST  The Daily Biotech Pulse: Lily-Rigel Licensing Deal, vTv Starts Early Stage Psoriasis Study, Immunic Data Readout   Benzinga
07:00AM EST  Silence Therapeutics to Present at the 2021 SVB Leerink Global Healthcare Conference   GlobeNewswire Inc
Feb 17, 2021
07:00AM EST  Silence Therapeutics Initiates Dosing in Phase 1 Clinical Trial of SLN360 for Cardiovascular Disease Due to High Lipoprotein(a)   GlobeNewswire Inc
Feb 9, 2021
08:10AM EST  The Daily Biotech Pulse: Dynavax Poaches GSK Vaccine Exec, KalVista Jumps On Data Readout, Corcept Issues Negative Preannouncement   Benzinga
Feb 5, 2021
07:00AM EST  Silence Therapeutics plc Announces $45 Million Private Placement   GlobeNewswire Inc
Feb 3, 2021
07:31AM EST  The Daily Biotech Pulse: Amgen Earnings, GSK-CureVac Vaccine Collaboration, Mallinckrodt FDA Decision   Benzinga
Jan 28, 2021
08:03AM EST  The Daily Biotech Pulse: Decision Day For Amgen, Zymeworks Sinks On Data, Ortho Clinical Diagnostics IPO   Benzinga
Jan 27, 2021
10:07AM EST  Stocks That Hit 52-Week Highs On Wednesday   Benzinga
07:36AM EST  The Daily Biotech Pulse: Sorrento, Immutep Surge On COVID-19 Study Data, T2 Biosystems Sinks On Preannouncement   Benzinga
Jan 26, 2021
08:07AM EST  The Daily Biotech Pulse: Novartis Misses, J&J Beats In Big Pharma Earnings, Vaccine Developer CureVac Taps Equity Market   Benzinga
Jan 6, 2021
07:31AM EST  The Daily Biotech Pulse: Aerpio Reviews Strategic Options, Hologic Goes Shopping   Benzinga
07:00AM EST  Silence Therapeutics Appoints Craig Tooman as Chief Financial Officer   GlobeNewswire Inc
07:00AM EST  Silence Therapeutics Appoints Michael H. Davidson, MD, to Board of Directors   GlobeNewswire Inc
Jan 5, 2021
08:39AM EST  The Daily Biotech Pulse: Moderna Coronavirus Vaccine Receives Third Regulatory Nod, Gritstone Rallies On Hedge Fund Stake, aTyr's COVID-19 Drug Data   Benzinga
07:00AM EST  Silence Therapeutics to Participate in January Virtual U.S. Investor Conferences   GlobeNewswire Inc
Nov 16, 2020
07:00AM EST  Silence Therapeutics Presents Positive Pre-Clinical Data for SLN360 for the Treatment of Elevated Lipoprotein(a) at American Heart Association 2020   GlobeNewswire Inc
Nov 4, 2020
08:21AM EST  The Daily Biotech Pulse: Alzheimer's Conference Underway, Biogen's Aducanumab Briefing Doc, Supernus Earnings   Benzinga
Nov 2, 2020
07:00AM EST  Silence Therapeutics Appoints Dr. Marie Wikstrm Lindholm to its Executive Leadership Team   GlobeNewswire Inc
Oct 29, 2020
07:30AM EDT  The Daily Biotech Pulse: Novartis Acquires Gene Therapy Company, Moderna's Japanese Vaccine Supply Deal   Benzinga
Oct 8, 2020
07:00AM EDT  THE INFORMATION CONTAINED WITHIN THIS ANNOUNCEMENT IS DEEMED BY THE COMPANY TO CONSTITUTE INSIDE INFORMATION AS STIPULATED UNDER THE EU MARKET ABUSE REGULATION (596/2014). UPON THE PUBLICATION OF THE ANNOUNCEMENT VIA A REGULATORY INFORMATION SERVICE, THIS INFORMATION IS CONSIDERED TO BE IN THE PUBLIC DOMAIN   GlobeNewswire Inc
Oct 1, 2020
07:00AM EDT  Silence Therapeutics to Participate in the Chardan Virtual 4th Annual Genetic Medicines Conference   GlobeNewswire Inc


Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2026 ChartExchange LLC